Zymeworks BC Operating Income

Zymeworks BC (ZYME) currently reports a operating income of $-110B as of June 2026. That compares with $-34B in the prior-year period — down 225.4% year over year. Use the charts on this page to explore Zymeworks BC's operating income history and peer comparisons.

Zymeworks BC's operating income decreased from $-34B to $-110B — a 225.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Zymeworks BC reported $-110B in operating income as of June 2026. That compares with $-34B in the prior-year period — down 225.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-110B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Zymeworks BC, and consider following ZYME for alerts when major investors trade the stock.

Zymeworks BC is classified in the Healthcare sector. On operating income, it currently shows $-110B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ZYME with unrelated industries.